Log in to save to my catalogue

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Different...

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Different...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2896801920

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

About this item

Full title

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

Publisher

Cham: Springer International Publishing

Journal title

Annals of surgical oncology, 2024-04, Vol.31 (4), p.2337-2348

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
The benefit of primary tumor resection in distant metastatic small bowel neuroendocrine tumors (SBNETs) is controversial, with treatment-based morbidity not well-defined. We aimed to determine the impact of primary tumor resection on development of disease-specific complications in patients with metastatic well-differentiated SBNETs.<...

Alternative Titles

Full title

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2896801920

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2896801920

Other Identifiers

ISSN

1068-9265,1534-4681

E-ISSN

1534-4681

DOI

10.1245/s10434-023-14637-3

How to access this item